Skip to main content

Table 2 Parameters for preferred risk incidence models in BEIR VII a

From: Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma

Cancer

ERR model

EAR model

βM

βF

γ

η

βM

βF

γ

η

Thyroid

0.53

1.05

−0.83

0.00

Not used

Lung

0.32

1.40

−0.30

−1.40

2.30

3.40

−0.41

5.20

Stomach

0.21

0.48

−0.30

−1.40

4.90

4.90

−0.41

2.80

Liver

0.32

0.32

−0.30

−1.40

2.20

1.00

−0.41

4.10

Colon

0.63

0.43

−0.30

−1.40

3.20

1.60

−0.41

2.80

Bladder

0.50

1.65

−0.30

−1.40

1.20

0.75

−0.41

6.00

Prostate

0.12

-

−0.30

−1.40

1.20

-

−0.41

2.80

Ovary

-

0.38

−0.30

−1.40

-

0.70

−0.41

2.80

  1. aFrom Table Twelve–Two (National Research Council 2006).